ClearanceBrief
Recall Z-2486-2025 ยท QVA Fludeoxyglucose F18-Guided Radiation Therapy System

Reflexion Medical, Inc.

RefleXion X1 Model RXM1000 UDI Codes: (01)00860003983812(11)230504(21)X11001 (01)00860003983812(11)230518(21)X11002 (01)00860003983812(11)230505(21)X11003 (01)00860003983812(11)230530(21)X11004 (01)00860003983812(11)230811(21)X11006 (01)00860003983812(11)230410(21)X11007 (01)00860003983812(11)230803(21)X11008 (01)00860003983812(11)240528(21)X11009 (01)00860003983812(11)240820(21)X11010 (01)0086000

DateSep 2, 2025 (initiated Jul 22, 2025)
StatusOpen, Classified
ReasonDue to incorrect software configuration that potentially allows more than two (2) fractions within a 12-hour period (fractionLimits) and could potentially lead to adverse events (toxicity).
Root causeSoftware change control
ActionOn 07/22/2025, the firm sent an "Urgent Medical Device Recall Safety Notification (Correction)" Letter to customer informing them that RefleXion is initiating a Recall (Correction) of the RefleXion X1 System (model RXM1000). An issue has been identified with a configuration setting for the maximum number of fractions that can be delivered within a specified time period. The system should be configured to allow the delivery of up to two (2) fractions, including completion of partial fractions, for each treatment plan within a 12-hour period. As a result of this issue there is a potential to uni
Quantity11
DistributionU.S. Nationwide distribution in the states of CA, CT, LA, NJ, OR, PA, and TX.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

This recall record lists no 510(k) number.